Cancer Screening

Having a primary care provider raises the likelihood of being up to date on cervical cancer screening, regardless of sexual orientation, but the association was greatest among lesbian, gay and bisexual women, according to researchers.

The 10-year interval between screening colonoscopies “could potentially be extended” to 15 years among patients without a family history of colorectal cancer and negative findings for CRC at the first colonoscopy, researchers reported.

Women should be screened for breast cancer every other year starting at age 40 years, according to a new recommendation statement from the U.S. Preventive Services Task Force.

The Patient-Centered Outcomes Research Institute awarded almost $10.5 million to Alliance NCTN Foundation to assess the value of remote digital screening for financial hardship to improve patient-centered outcomes in patients with cancer.

In a Healio video exclusive, Shria Kumar, MD, MSCE, discusses how community-based eradication of Helicobacter pylori infection may reduce the risk for gastric cancer in historically underrepresented communities and other vulnerable groups.

Researchers estimated that nearly 60 million individuals aged 45 to 85 years are at average-risk for colorectal cancer and eligible for screening in the U.S., according to cross-sectional study data in JAMA Network Open.

A 10-minute video designed to educate Black men on prostate cancer risks prompted 93% of viewers to report they intend to be screened in the future, according to study results presented at American Association for Cancer Research Annual Meeting.

In a Healio video exclusive, Austin L. Chiang, MD, MPH, discusses his new book, “Gut: An Owner’s Guide,” which he hopes will help readers become “more empowered and better informed” about their gastrointestinal health.

In this episode, host Shikha Jain, MD, speaks with Aparna Parikh, MD, about cancer and GI malignancies in the global health space, circulating tumor DNA in the field of oncology and more.

A quality performance measure that tracks follow-up colonoscopy rates within 6 months of an abnormal stool-based screening test was feasible and had a median reliability of 94.5% across health care organizations, according to researchers.